Clinical Trials

NCT03939481 | ACTIVE_NOT_RECRUITING
1336 participants

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-08
Start Date:
2019-05-14
Completion:
2025-04-08
Conditions
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage IA Breast Cancer AJCC v8
  • Anatomic Stage IB Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • Anatomic Stage IIIC Breast Cancer AJCC v8
  • Lung Non-Small Cell Carcinoma
  • Prognostic Stage I Breast Cancer AJCC v8
  • Prognostic Stage IA Breast Cancer AJCC v8
  • Prognostic Stage IB Breast Cancer AJCC v8
  • Prognostic Stage II Breast Cancer AJCC v8
  • Prognostic Stage IIA Breast Cancer AJCC v8
  • Prognostic Stage IIB Breast Cancer AJCC v8
  • Prognostic Stage III Breast Cancer AJCC v8
  • Prognostic Stage IIIA Breast Cancer AJCC v8
  • Prognostic Stage IIIB Breast Cancer AJCC v8
  • Prognostic Stage IIIC Breast Cancer AJCC v8
  • Stage I Lung Cancer AJCC v8
  • Stage I Ovarian Cancer AJCC v8
  • Stage IA Ovarian Cancer AJCC v8
  • Stage IA1 Lung Cancer AJCC v8
  • Stage IA2 Lung Cancer AJCC v8
  • Stage IA3 Lung Cancer AJCC v8
  • Stage IB Lung Cancer AJCC v8
  • Stage IB Ovarian Cancer AJCC v8
  • Stage IC Ovarian Cancer AJCC v8
  • Stage II Lung Cancer AJCC v8
  • Stage II Ovarian Cancer AJCC v8
  • Stage IIA Lung Cancer AJCC v8
  • Stage IIA Ovarian Cancer AJCC v8
  • Stage IIB Lung Cancer AJCC v8
  • Stage IIB Ovarian Cancer AJCC v8
  • Stage III Lung Cancer AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIA Ovarian Cancer AJCC v8
  • Stage IIIA1 Ovarian Cancer AJCC v8
  • Stage IIIA2 Ovarian Cancer AJCC v8
  • Stage IIIB Lung Cancer AJCC v8
  • Stage IIIB Ovarian Cancer AJCC v8
  • Stage IIIC Lung Cancer AJCC v8
  • Stage IIIC Ovarian Cancer AJCC v8
Interventions
  • DRUG
  • OTHER
NCT03289962 | COMPLETED | PHASE1
273 participants

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-08
Start Date:
2017-12-21
Completion:
2025-07-01
Conditions
  • Melanoma
  • Non-Small Cell Lung Cancer
  • Bladder Cancer
  • Colorectal Cancer
  • Triple Negative Breast Cancer
  • Renal Cancer
  • Head and Neck Cancer
  • Other Solid Cancers
Interventions
  • DRUG
No Results Yet
NCT03146871 | TERMINATED | PHASE2
7 participants

Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-08
Start Date:
2017-04-20
Completion:
2019-03-19
Conditions
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • Previously Treated Myelodysplastic Syndrome
  • Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Recurrent Adult Acute Myeloid Leukemia
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
NCT02734602 | ACTIVE_NOT_RECRUITING | NA
130 participants

Imaging SV2A in Mood Disorders

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-08
Start Date:
2016-04-30
Completion:
2027-01-31
Conditions
  • Major Depressive Disorder
  • Post-Traumatic Stress Disorder
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page